These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 14759451

  • 1. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK, Datta SK, Muhlbaier LH, Samsa G, Nadel A, Lipscomb J.
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [Abstract] [Full Text] [Related]

  • 2. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.
    Chen JC, Kaul P, Levy JH, Haverich A, Menasché P, Smith PK, Carrier M, Verrier ED, Van de Werf F, Burge R, Finnegan P, Mark DB, Shernan SK, PRIMO-CABG Investigators.
    Crit Care Med; 2007 May; 35(5):1296-301. PubMed ID: 17414091
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS, White C, Gu J, Brown J, Gammie J, Pierson RN, Lee A, Connerney I, Avari T, Christenson R, Tandry U, Griffith BP.
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [Abstract] [Full Text] [Related]

  • 6. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM, Jackson LR, Chatwin C, Smolich JJ.
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J, Lindvall G, Sartipy U.
    Circulation; 2005 Aug 30; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.
    Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Culler SD, Dee AD, Simon AW.
    Ann Thorac Surg; 2008 Jun 30; 85(6):1980-6. PubMed ID: 18498806
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C, Barbagallo R, Capodanno D, di Matteo S, Colombo GL, Recchia M, Ciriminna S, Sicilian DES Registry Investigators.
    J Cardiovasc Med (Hagerstown); 2009 Apr 30; 10(4):322-9. PubMed ID: 19430343
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale.
    Mehta RH, Alexander JH, Emery R, Ellis SJ, Hasselblad V, Khalil A, Carrier M, Harrington RA, Tardif JC, MEND-CABG II Investigators.
    Am Heart J; 2008 Apr 30; 155(4):600-8. PubMed ID: 18371465
    [Abstract] [Full Text] [Related]

  • 16. Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity.
    Scott BH, Seifert FC, Grimson R, Glass PS.
    J Cardiothorac Vasc Anesth; 2005 Oct 30; 19(5):583-8. PubMed ID: 16202890
    [Abstract] [Full Text] [Related]

  • 17. Cost-offset analysis of aprotinin in high-risk coronary artery bypass.
    Meek PD, Vlasses PH, Sura ME, Walsh RE, Vermeulen LC.
    Pharm Pract Manag Q; 1999 Jul 30; 19(2):18-25. PubMed ID: 10558092
    [Abstract] [Full Text] [Related]

  • 18. A cost analysis of nonelective coronary artery bypass graft surgery.
    Violette PD, Filion KB, Haider S, Pilote L, Eisenberg MJ.
    J Card Surg; 2006 Jul 30; 21(6):621-7. PubMed ID: 17073972
    [Abstract] [Full Text] [Related]

  • 19. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA.
    Circulation; 2007 Mar 06; 115(9):1082-9. PubMed ID: 17339566
    [Abstract] [Full Text] [Related]

  • 20. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G, Sartipy U, van der Linden J.
    Ann Thorac Surg; 2005 Sep 06; 80(3):922-7. PubMed ID: 16122456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.